Established in December 2000, WuXi PharmaTech is a leading global pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in both China and the U.S. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to pharmaceutical, biotechnology and medical device companies. Our services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D.
Our senior management team consists of Ph.D.s and MBAs with experience in drug and medical device R&D methodologies and international business practices. Collectively, our senior management has more than 200 patents pending or granted, published more than 800 publications and has an average of 14 years of experience working in major international pharmaceutical, biotechnology and medical device companies. The company's total number of employees is over 3,300.
We are well-positioned to capitalize on the advantages of conducting R&D in China, while emphasizing quality, responsiveness, protection of customer intellectual property and reliability. Our primary China-based facilities include a 630,000 square-foot R&D center in Shanghai Waigaoqiao Free Trade Zone, a 220,000 square-foot process development and cGMP-quality manufacturing plant in Jinshan area of Shanghai, and a 130,000 square foot R&D center in Tianjin, which is mainly focused on discovery chemistry services. Our U.S.-based facilities are all FDA-registered, including a 63,000 square-foot R&D and manufacturing facility in St. Paul, Minnesota, a 46,000 square-foot testing facility in Atlanta, Georgia, and a 75,000 square-foot R&D and testing facility in Philadelphia, Pennsylvania.